ETN
61
2
NVDA
57
-2
FSLR
60
-10
ROST
70
2
BK
77
2
GIS
54
2
GWW
65
3
DUK
59
4
MTB
75
2
IFF
62
5
AIV
48
4
CNP
55
3
GT
39
2
VLO
40
-2
AEE
58
3
NKE
36
6
URBN
54
2
EQT
51
-5
XRAY
28
3
FITB
72
2
ETN
61
2
NVDA
57
-2
FSLR
60
-10
ROST
70
2
BK
77
2
GIS
54
2
GWW
65
3
DUK
59
4
MTB
75
2
IFF
62
5
AIV
48
4
CNP
55
3
GT
39
2
VLO
40
-2
AEE
58
3
NKE
36
6
URBN
54
2
EQT
51
-5
XRAY
28
3
FITB
72
2
Financhill
Back

T-Mobile US, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
35

TMUS
T-Mobile US, Inc.

Last Price:
$201.03
Seasonality Move:
9.89%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
35
T-Mobile US, Inc. (TMUS) is a Sell

Is T-Mobile US, Inc. a Buy, Sell or Hold?

  • The current T-Mobile US, Inc. [TMUS] share price is $199.02. The Score for TMUS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • TMUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TMUS Stock Price Chart

What is T-Mobile US, Inc.'s stock price today?

  • The T-Mobile US, Inc. share price today is $199.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMUS is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

TMUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 52.09 Buy
Relative Strength Index (14 RSI): 41.62 Sell
Chaikin Money Flow: 1159154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (197.4 - 208.9) Sell
Bollinger Bands (100): (206.88 - 245.2) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

TMUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 197.87 Buy
20-day SMA: 201.66 Sell
50-day SMA: 209.49 Sell
200-day SMA: 235.15 Sell
8-day EMA: 154.17 Buy
20-day EMA: 89.42 Buy
50-day EMA: 42.28 Buy
200-day EMA: 11.54 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

T-Mobile US, Inc. Earnings Growth & TMUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.73 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

T-Mobile US, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):